FDA approves Medicines Co's blood clot drug after a decade

(Reuters) - The U.S. Food and Drug Administration on Monday approved Medicines Co's blood clot preventer Cangrelor, which has faced multiple setbacks since it first entered late-stage studies close to a decade back.